The 17 references in paper A. Kotov S., Yu. Tokareva V., V. Lutsik N., M. Panteleeva V., A. Shatalin V., E. Mukhina V., M. Bunak S., O. Andryukhina M., А. Котов С., Ю. Токарева В., В. Луцик Н., М. Пантелеева В., А. Шаталин В., Е. Мухина В., М. Бунак С., О. Андрюхина М. (2018) “Расстройство из спектра оптиконевромиелита в детском возрасте (клинический случай) // Neuromyelitis optica spectrum disorder in childhood (a case report)” / spz:neicon:rjdn:y:2017:i:4:p:56-62

1
Котов А.С., Андрюхина О.М., Матюк Ю.В. и др. Оптический неврит и миелит у подростка: оптикомиелит Девика или рассеянный склероз? Неврологический журнал 2015;20(6):35–40. [Kotov A.S., Andryukhina O.M., Matyuk Yu.V. et al. Optic neuritis and myelitis in an adolescent: optical neuromyelitis or multiple sclerosis? Nevrologicheskiy zhurnal = Neurological Journal 2015;20(6):35–40. (In Russ.)].
(check this in PDF content)
2
Луцик В.Н., Котов А.С., Борисова М.Н. и др. Оптикомиелит Девика у ребенка. Неврологический журнал 2017;22(4): 205–10. [Lutsik V.N., Kotov A.S., Borisova M.N. et al. Optical neuromyelitis in a child. Nevrologicheskiy zhurnal = Neurological Journal 2017;22(4):205–10. (In Russ.)].
(check this in PDF content)
3
Abboud H., Petrak A., Mealy M. et al. Treatment of acute relapses in neuromyelitis optica: steroids alone versus steroids plus plasma exchange. Mult Scler 2016;22(2):185–92. DOI: 10.1177/1352458515581438.
(check this in PDF content)
4
Bizzoco E., Lolli F., Repice A.M. et al. Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution. J Neurol 2009;256(11):1891–8. DOI: 10.1007/s00415-009-5171-x.
(check this in PDF content)
5
Coutinho A.E., Chapman K.E. The antiinflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol Cell Endocrinol 2011;335(1):2–13. DOI: 10.1016/j.mce.2010.04.005.
(check this in PDF content)
6
Wingerchuk D.M. Neuromyelitis optica spectrum disorders: diagnosis and treatment. J Neuroophthalmol 2011;31(4):292.
(check this in PDF content)
7
Jacob A., Matiello M., Weinshenker B.G. et al. Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients. Arch Neurol 2009;66(9):1128–33. DOI: 10.1001/archneurol.2009.175.
(check this in PDF content)
8
Jiao Y., Fryer J.P., Lennon V.A. et al. Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica. Neurology 2013;81(14):1197–204. DOI: 10.1212/WNL.0b013e3182a6cb5c.
(check this in PDF content)
9
Killian J.M., Bressler R.B., Armstrong R.M., Huston D.P. Controlled pilot trial of monthly intravenous cyclophosphamide in multiple sclerosis. Arch Neurol 1988;45(1):27–30. PMID: 3276298.
(check this in PDF content)
10
Mandler R.N., Ahmed W., Dencoff J.E. Devic’s neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine. Neurology 1998;51(4):1219–20. PMID: 9781568.
(check this in PDF content)
11
Matiello M., Jacob A., Wingerchuk D.M., Weinshenker B.G. Neuromyelitis optica. Curr Opin Neurol 2007;20(3):255–60. DOI: 10.1097/WCO.0b013e32814f1c6b.
(check this in PDF content)
12
Oh J., Levy M. Neuromyelitis optica: an antibody-mediated disorder of the central nervous system. Neurol Res Int 2012;2012:460825. DOI: 10.1155/2012/460825.
(check this in PDF content)
13
Pandit L. Neuromyelitis optica spectrum disorders: an update. Ann Indian Acad Neurol 2015;18(suppl 1):S11–5. DOI: 10.4103/0972-2327.164816.
(check this in PDF content)
14
Sherman E., Han M. Acute and chronic management of neuromyelitis optica spectrum disorder. Curr Treat Options Neurol 2015;17(11):48. DOI: 10.1007/s11940015-0378-x.
(check this in PDF content)
15
Wingerchuk D.M., Banwell B., Bennett J.L. et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015;85(2):177–89. DOI: 10.1212/ WNL.0000000000001729.
(check this in PDF content)
16
Wingerchuk D.M. Neuromyelitis optica: effect of gender. J Neurol Sci 2009;286(1–2): 18–23. DOI: 10.1016/j.jns.2009.08.045.
(check this in PDF content)
17
Zaffaroni M., Italian Devic’s Study Group. Cerebrospinal fluid findings in Devic’s neuromyelitis optica. Neurol Sci 2004;25(suppl 4):S368–70. PMID: 15727236.
(check this in PDF content)